1-4 of 4
Shin Nakayama
Close
Sort by
Journal Articles

Imatinib Mesylate Has a Stage-Specific Inhibitory Role in Generation of CD26 high CD8 + Central Memory T Cells in Vitro and in Vivo .

Kazuaki Yokoyama, MD, Tokiko Nagamura-Inoue, MD, PhD, Shin Nakayama, Ikuo Ishige, Kazuo Ogami, Munenori Futami, Seiichirou Kobayashi, Arinobu Tojo, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 3243.
https://doi.org/10.1182/blood.V112.11.3243.3243
Published: 2008
Journal Articles

Large Scale Selective Ex Vivo Expansion of CD4 + CD25 + FOXP3 + Regulatory T Cells from Peripheral Blood.

Tokiko Nagamura-Inoue, MD, PhD, Kazuo Ogami, Kazuaki Yokoyama, Kiyoko Izawa, Seiichiro Kobayashi, Shin Nakayama, Ikuo Ishige, Yusuke Inoue, Jun Ooi, Kaoru Uchimaru, Satoshi Takahashi, Arinobu Tojo
Journal: Blood
Blood (2008) 112 (11): 2344.
https://doi.org/10.1182/blood.V112.11.2344.2344
Published: 2008
Journal Articles

Immunomodulatory Influence by Interferon alpha and Imatinib Mesylate in Chronic Myeloid Leukemia.

Kazuaki Yokoyama, Tokiko Nagamura-Inoue, Shin Nakayama, Ikuo Ishige, Nobuhiro Ohno, Satoshi Takahashi, Kaoru Uchimaru, Toru Iseki, Arinobu Tojo
Journal: Blood
Blood (2007) 110 (11): 4534.
https://doi.org/10.1182/blood.V110.11.4534.4534
Published: 2007
Journal Articles

Impact of Acute GVHD on Immune Reconstitution after Cord Blood Transplantation in Adult.

Tokiko Nagamura-Inoue, MD.PhD, Satoshi Takahashi, MD.PhD., Jun Ooi, MD., Akira Tomonari, MD.PhD., Toru Iseki, MD.PhD., Kaoru Uchimaru, MD.PhD., Fumitaka Nagamura, MD.PhD., Nobuhiro Ohno, MD., Kashiya Takasugi, MD, Munechika Futami, MD, Michihiro Uchiyama, MD, Yasushi Soda, MD.PhD, Taka-aki Konuma, MD, Shin Nakayama, MD, Mika Shioya, Nobukazu Watanabe, MD.PhD, Shigetaka Asano, MD.PhD, Arinobu Tojo, MD.PhD, Tsuneo A. Takahashi, D.Sc.
Journal: Blood
Blood (2004) 104 (11): 984.
https://doi.org/10.1182/blood.V104.11.984.984
Published: 2004